- Home
- Automated
- List of product information
- CLARITYN-D 12HOUR REPETABS [SIN07282P]
CLARITYN-D 12HOUR REPETABS [SIN07282P]
Active ingredients: CLARITYN-D 12HOUR REPETABS
Last updated 26 October 2025
Product Info
CLARITYN-D 12HOUR REPETABS
[SIN07282P]
Product information
Active Ingredient and Strength | LORATADINE - 5 MG |
Dosage Form | TABLET, SUGAR COATED |
Manufacturer and Country | SAG MANUFACTURING SLU - SPAIN |
Registration Number | SIN07282P |
Licence Holder | BAYER (SOUTH EAST ASIA) PTE LTD |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R01BA52 |
Indications and usage
Clarityn-D® 12Hour Repetabs is indicated for the relief of symptoms associated with allergic rhinitis and the common cold including nasal congestion, sneezing, rhinorrhea, pruritus and lacrimation.
Clarityn-D® 12Hour Repetabs is recommended when both the antihistaminic properties of loratadine and the decongestant effect of pseudoephedrine sulfate are desired.
Dosage and administration
Adults and Children 12 years of age and over: One Clarityn-D® 12Hour Repetabs tablet twice a day.
Contraindications
Clarityn-D® 12Hour Repetabs are contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components, to adrenergic agents or to other drugs of similar chemical structure. Clarityn-D® 12Hour Repetabs are also contraindicated in patients receiving MAO inhibitor therapy or within 2 weeks of discontinuing such treatment and in patients with narrow angle glaucoma, urinary retention, severe hypertension, severe coronary artery disease and hyperthyroidism.